Динамика уровня адипонектина в крови при лечении ожирения у подростков: сравнение двух вариантов терапии
Аннотация
Список литературы
1. Luttikhuis H.O., Baur L., Jansen H., Shrewsbury V.A., O'Malley C., Stolk R.P., Summerbell C.D. Interventions for treating obesity in children (Review). The Cochrane Library 2009, Issue 1.
2. Wilfley D.E., Tibbs T.L., Van Buren D.J., Reach K.P., Walker M.S., Epstein L.H. Lifestyle interventions in the treatment of childhood overweight: a metaanalytic review of randomized controlled trials. Health Psychol 2007; 26: 521-532.
3. McGovern L., Johnson J.N., Paulo R., Hettinger A., Singhal V., Kamath C., Erwin P.J., Montori V.M. Clinical review: treatment of pediatric obesity: a systematic review and metaanalysis of randomized trials. J Clin Endocrinol Metabol 2008; 93: 4600-4605.
4. Skelton J.A., DeMattia L.G., Flores G. A pediatric weight management program for high-risk populations: a preliminary analysis. Obesity: Silver Spring 2008; 16: 1698-1701.
5. Chanoine J.P., Hampl S., Jensen C., Boldrin M., Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005; 293: 23: 2873-2883.
6. Maahs D., de Serna D.G., Kolotkin R.L., Ralston S., Sandate J., Qualls C., Schade D.S. Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocrin Pract 2006; 12: 1: 18-28.
7. Мельниченко Г.А., Петеркова В.А., Савельева Л.В., Зубкова Н.А. Оценка эффективности применения Ксеникала в комплексной терапии ожирения у подростков с метаболическим синдромом. Ожирение и метаболизм 2012; 4: 36-42.
8. Madsen K.A., Garber A.K., Mietus-Snyder M.L. A clinic-based lifestyle intervention for pediatric obesity: efficacy and behavioral and biochemical predictors of response. J Pediatr Endocrinol Metabol 2009; 22: 9: 805-814.
9. Stotland S.C., Larocque M. Early treatment response as a predictor of ongoing weight loss in obesity treatment. Br J Health Psychol 2005; 10: Pt 4: 601-614.
10. Canoine J.-P., Richard M. Early weight loss and outcome at one year in obese adolescents treated with orlistat or placebo. Int J Pediatr Obes 2011; 6: 95-101.
11. Reinehr T., Kiess W., Kapellen T., Andler W. Insulin sensitivity among obese children and adolescents according to degree of weight loss. Pediatrics 2004; 114: 1569-1573.
12. Pinhas-Hamiel O., Lerner-Geva L., Copperman N., Jacobson M.S. Insulin resistance and parental obesity as predictors to response to therapeutic life style change in obese children and adolescents 10-18 years old. J Adolesc Health 2008; 43: 437-443.
13. Cummings D.M., Henes S., Kolasa K.M., Olsson J., Collier D. Insulin resistanee status: predicting weight response in overweight children. Arch Pediatr Adolesc Med 2008; 162: 764-768.
14. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476.
15. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., Fu Y., Motone M., Yamamoto K., Matsuo A., Ohashi K., Kihara S., Funahashi T., Rakugi H., Matsuzawa Y., Ogihara T. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318-1323.
16. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metabol 2001; 86: 1930-1935.
17. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxisal decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
18. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., Arita Y., Okamoto Y., Shimomura I., Hiraoka H., Nakamura T., Funahashi T., Matsuzawa Y. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thrombol Vasc Biol 2003; 23: 85-89.
19. Петеркова В.А., Косыгина А.В., Васюкова О.В. Адипонектин сыворотки крови при ожирении у детей. Пробл эндокринол 2011; 6: 9-14.
20. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabet Care 1999; 22: 1462-1470.
21. Savoye M., Shaw M., Dziura J., Tamborlane W.V., Rose P., Guandalini C., Goldberg-Gell R., Burgert T.S., Cali A.M., Weiss R., Caprio S. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA 2007; 297: 2697-2704.
22. Reinehr T., Andler W. Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child 2004; 89: 419-422.
23. Czernichow S., Lee C.M., Barzi F., Greenfield J.R., Baur L.A., Chalmers J., Woodward M., Huxley R.R. Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a metaanalysis of randomized controlled trials. Obes Rev 2010; 11: 150-158.
24. Wayne S., Cutfield P.L. Hofman simple fasting methods to assess insulin sensitivity in childhood. Horm Res 2005; 64: 3: 25-31.
Рецензия
Для цитирования:
., ., . Динамика уровня адипонектина в крови при лечении ожирения у подростков: сравнение двух вариантов терапии. Проблемы Эндокринологии. 2013;59(2):26-33. https://doi.org/10.14341/probl201359226-33
For citation:
Peterkova V.A., Vasiukova O.V., Okorokov P.L. Dynamics of the blood adiponectin levels during treatment of obesity in the adolescents: comparison of two therapeutic modalities. Problems of Endocrinology. 2013;59(2):26-33. https://doi.org/10.14341/probl201359226-33
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Послать статью по эл. почте 
.jpg){kind=logo}
